Please login to the form below

Not currently logged in
Email:
Password:

migraines

This page shows the latest migraines news and features for those working in and with pharma, biotech and healthcare.

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again. Aimovig will become the first CGRP receptor-targeting drug if it reaches market. ... In the control group just under 14% of patients achieved a 50% reduction in migraine days.

Latest news

More from news
Approximately 15 fully matching, plus 120 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    III CGRP antibody for the treatment of migraine.

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • The cultural construction of illness The cultural construction of illness

    Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her

  • Ditch the data? Ditch the data?

    Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.

  • Deal Watch January 2017 Deal Watch January 2017

    1, 000. CoLucid. Lilly. Company acquisition. Lasmiditan for the acute treatment of migraine.

More from intelligence
Approximately 2 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Double Communiqué award win for 90TEN

    The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:

  • What it takes to win at Cannes Health Lions

    As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for  Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s

  • 90TEN nominated for five Communique Awards including Small Consultancy of the Year

    The Allergan “ Migraine Unlocked” campaign is a finalist in Excellence in Communications via a Live Event or Stand-Alone Activity, and an HCV programme for AbbVie has been recognised in the

  • Double Communiqué award win for 90TEN

    The Migraine Unlocked campaign took a surround-sound communications approach using advertising, media and grassroots campaigning to maximise exposure to sufferers and their loved ones. ... Commenting on Migraine Unlocked, t he Comm uniqué judges said:

  • What it takes to win at Cannes Health Lions

    As for Martin, DDB Remedy won a Silver and Two bronze awards for an integrated campaign for  Excedrin, an OTC migraine treatment in the US, helping to address the issue that ... people often respond to someone with a migraine by just saying that it’ s

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics